BNTX
$97.64+0.76%
as of close, Oct 5, 2026
☾ AH $97.64 +0.76%
BioNTech SE American Depositary ShareStock · Health Care
BNTX — BioNTech SE American Depositary Share price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDEEEE
50.0100.0150.0200.0250.0300.0350.0020.0M40.0M$97.64—20192021202320252026
2026-10-05
Price$97.64
MA20$96.39
MA50$97.88
Vol2.9M
Key stats#
Price data
- Price
- $97.64
- YTD price return
- +2.56%
- YTD total return
- +2.56%
- Next earnings
- Nov 3, 2026 · Before open
- Market cap
- 24.5B
- Enterprise value
- 15.5B
- Shares outstanding
- 251.2M
- 52W low
- $79.52
- 52W high
- $124.00
- From 52W high
- -21.26%
- From 52W low
- +22.79%
- 52W range
- 41%
- Beta
- 1.26
Volume
- Rel volume
- 1.38×
- 30D volume
- 1M
- 30D $ vol
- 106.3M
Insider trading
- Insider net 1W
- −$6.4M
- Insider net 1M
- −$59.1M
- Insider net 3M
- −$67.0M
- Insider net 1Y
- −$72.5M
Form 4 transactions by trade date, as filed; latest on file 2026-10-02.
Fundamentals
- Sales (ttm)
- 3.2B
- Sales/share
- $12.93
- EPS (ttm)
- -$5.32
- FCF (ttm)
- 516M
- FCF/share
- $2.05
- Book value/share
- $89.89
- Net margin
- -39.59%
- ROE
- -5.69%
- ROA
- -4.98%
- Current ratio
- 7.54
Growth (CAGR, ttm) · 10Y
- Sales
- +9.09%-43.70%+42.65%n/a
- Shares
- +4.68%+1.39%+0.79%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +4.21%-44.47%+41.54%n/a
- Book value/share
- +6.56%+0.44%+66.82%n/a
- Price
- -7.17%-3.85%-17.15%n/a
- Total return
- -7.17%-3.85%-16.93%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -18.4×
- P/OI (ttm)
- 35.8×
- Fwd P/E
- -17.5×
- P/S (ttm)
- 7.6×
- P/B (mrq)
- 1.1×
- P/FCF (ttm)
- 47.5×
- EV/Sales (ttm)
- 4.8×
- FCF yield (ttm)
- 2.10%
- Buyback yield (realized, 1y)
- -4.68%
- Shareholder yield (realized, 1y)
- -4.68%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/E
- 70th
- P/OI
- 93rd
- P/S
- 50th
- P/B
- 17th
Bar = where today’s multiple sits in BNTX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-05#
1D
+0.76%
5D
-1.45%
1M
-5.90%
3M
+0.10%
YTD
+2.56%
1Y
-7.44%
5Y
-60.96%
Recent filings#
- Oct 2Insider sale · Sahin Ugur (Chief Executive Officer · 10% owner) sold 17,000 shares for $1.6M at $96.72 under a 10b5-1 plan
- Oct 1Insider sale · Sahin Ugur (Chief Executive Officer · 10% owner) sold 17,000 shares for $1.7M at $97.46 under a 10b5-1 plan
- Sep 30Insider sale · Sahin Ugur (Chief Executive Officer · 10% owner) sold 32,000 shares for $3.1M at $98.12 under a 10b5-1 plan
- Sep 29Insider sale · Sahin Ugur (Chief Executive Officer · 10% owner) sold 34,000 shares for $3.3M at $98.26 under a 10b5-1 plan
- Sep 28Insider sale · Sahin Ugur (Chief Executive Officer · 10% owner) sold 34,000 shares for $3.3M at $98.47 under a 10b5-1 plan
Financial statements
Open full BNTX financials →Loading financial statements…
Related Health Care#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| NVS | Novartis AG | -11.91% | -0.05% |
| NVO | Novo Nordisk A/S | -19.44% | +0.59% |
| SNY | Sanofi ADS | -10.69% | -1.03% |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | -6.69% | -1.02% |
| NTRA | Natera Inc. | +29.70% | +3.73% |
| ARGX | argenx SE American Depositary Shares | -11.64% | -0.69% |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | -3.47% | -0.28% |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | +9.08% | +0.33% |
